Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults

Connor A Emdin1, Simon G Anderson1,2, Gholamreza Salimi-Khorshidi1

  • 1George Institute for Global Health, University of Oxford, Oxford, UK.

Insights

Elevated blood pressure increases atrial fibrillation (AF) risk, especially in younger adults. AF without antithrombotic use significantly raises the risk of eight major vascular events.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Elevated blood pressure is a known risk factor for atrial fibrillation (AF).
  • The influence of individual characteristics on the blood pressure-AF association is not well understood.
  • Quantification of AF's association with various vascular events requires further investigation.

Purpose of the Study:

  • To examine the association between elevated blood pressure and the risk of atrial fibrillation (AF) across different age groups.
  • To quantify the risk of nine distinct vascular events in patients diagnosed with AF.
  • To investigate the impact of antithrombotic usage on the risk of vascular events in AF patients.

Main Methods:

  • Utilized linked electronic health records from a large UK cohort (4.3 million adults aged 30-90).
  • Analyzed time to first diagnosis of AF and nine vascular events.
  • Employed survival analysis to estimate hazard ratios (HR) and confidence intervals (CI).

Main Results:

  • A 20-mmHg increase in systolic blood pressure was linked to a 21% higher risk of AF (HR 1.21).
  • The blood pressure-AF association weakened significantly with advancing age.
  • AF patients without antithrombotic use showed a substantially higher risk of eight vascular events, including ischemic heart disease, heart failure, and stroke.

Conclusions:

  • The association between elevated blood pressure and AF risk diminishes with increasing age.
  • Atrial fibrillation diagnosed without concurrent antithrombotic medication use is a significant risk factor for multiple vascular events.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
824
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
571
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K